How to pronounce “immunotherapy” in English

So immunotherapy has had amazing advances in diseases like melanoma, in metastatic melanoma, and certain types of lung cancers.

There's an immunotherapy that's binary.

Almost as many immunotherapy companies as there are video sharing companies, I think, out there.

The first is what we call immunotherapy.

I have a new chemotherapy or a new immunotherapy that will prolong patients' lives on average by six months.

So there is a fair amount of excitement about immunotherapy.

And with personalized medicine, with immunotherapy, which was once kind of pooh-poohed in the cancer world, bolstering your immune system to kill

And so I think the exact same thing that we're learning now with immunotherapy for HIV, for cancer, for all those things about teaching our body that this is bad, I think we're now

Now, if you're trying to do a targeted immunotherapy for melanoma-- like you so brilliantly-- I mean, I don't know if you know Jack's dad-- is

So if you're doing something like that, I think a targeted immunotherapy or whatever is brilliant.

We have new CDK4/6 inhibitors, and there's excitement about immunotherapy.

The attractive thing if this works, though, is that immunotherapy, such as a vaccine, for example, could be applied to either treat metastatic disease, prevent

I wasn't going to reach the largest number of people in the world with writing about genomics or cancer immunotherapy.

This is part of the story of the last five years, is that immunotherapy has really come to the fore in cancer.

US health delivers miracles every day, particularly when it comes to cutting edge and intensive care things like transplants, cancer immunotherapy, and gene editing.

But it's worth noting that the idea of editing cells for therapeutic purposes is already really widely deployed, especially in immunotherapy.

Jack, who's not an oncologist, decided he would learn everything he could about melanoma, developed a treatment-- an immunotherapy-- and his dad is cured.

I mean, we shouldn't abandon the amazing work that's going on today, for example, in cancer immunotherapy, which is truly transformative.

So for those unfamiliar, Novartis won FDA approval just a couple of weeks ago for the first CAR-T immunotherapy,

with Genentech, umm; I've written a book about cancer immunotherapy.

So cancers like skin cancer melanoma, like kidney cancer, some types of lung cancer and others have had some pretty dramatic results with this immunotherapy and it's only getting

So we're learning a lot, new ways to target the cancer and treat it, immunotherapy, molecular targeted therapy, and at the same time looking to change that system so the cancer doesn't